Moreover, LRPAP121–30-specific CD8 T cells were present in the natural repertoire of all tested HLA-A2 positive healthy donors and in vitro stimulated T cells were capable of targeting these HLA class Ilow immune-escaped cancers. The gene discussed is CD8A; the disease is cancer.